Adamis Pharmaceuticals Corporation Profile Avatar - Palmy Investing

Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candid…

Drug Manufacturers - Specialty & Generic
US, San Diego [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Adamis Pharmaceuticals Corporation can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Adamis Pharmaceuticals Corporation can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Adamis Pharmaceuticals Corporation.

If you want to see a demo, head over to the financial segments of AAPL

End of ADMP's Analysis
CIK: 887247 CUSIP: 00547W208 ISIN: US00547W2089 LEI: - UEI: -
Secondary Listings
ADMP has no secondary listings inside our databases.